Thromboprophylaxis for medical inpatients with coronavirus disease 2019.
作者信息
Dalager-Pedersen M, Bodilsen J
机构信息
Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
出版信息
Clin Microbiol Infect. 2020 Sep;26(9):1125-1126. doi: 10.1016/j.cmi.2020.05.021. Epub 2020 May 23.
Abstract
摘要
相似文献
1
Thromboprophylaxis for medical inpatients with coronavirus disease 2019.
Clin Microbiol Infect. 2020 Sep;26(9):1125-1126. doi: 10.1016/j.cmi.2020.05.021. Epub 2020 May 23.
2
Thromboprophylaxis and anticoagulation for inpatients with COVID-19 in 2022 and beyond.
Clin Microbiol Infect. 2022 Sep;28(9):1184-1186. doi: 10.1016/j.cmi.2022.05.027. Epub 2022 May 29.
3
[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
Medicina (B Aires). 2020;80 Suppl 3:65-66.
4
Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
Swiss Med Wkly. 2020 Jun 21;150:w20301. doi: 10.4414/smw.2020.20301. eCollection 2020 Jun 15.
5
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis.
Swiss Med Wkly. 2020 Apr 11;150:w20247. doi: 10.4414/smw.2020.20247. eCollection 2020 Apr 6.
6
Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey.
Br J Anaesth. 2021 Oct;127(4):e143-e145. doi: 10.1016/j.bja.2021.06.041. Epub 2021 Jul 9.
7
Thromboprophylaxis in Patients With Cancer and COVID-19.
Arch Bronconeumol. 2022 Nov;58(11):744-745. doi: 10.1016/j.arbres.2022.08.006. Epub 2022 Sep 8.
8
Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient Management.
R I Med J (2013). 2022 Aug 1;105(6):36-40.
9
Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management.
Eur J Intern Med. 2020 Dec;82:18-20. doi: 10.1016/j.ejim.2020.10.018. Epub 2020 Oct 22.
10
Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.
Medicina (Kaunas). 2020 Sep 27;56(10):506. doi: 10.3390/medicina56100506.
引用本文的文献
1
Mortality, critical illness, and mechanical ventilation among hospitalized patients with COVID-19 on therapeutic anticoagulants.
Thromb Update. 2021;2:100027. doi: 10.1016/j.tru.2020.100027. Epub 2021 Mar 19.
2
'Convalescent Plasma'- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review.
Infect Disord Drug Targets. 2022;22(8):42-60. doi: 10.2174/1871526522666220425103031.
3
'Treatment of COVID-19 with convalescent plasma' - Author's reply.
Clin Microbiol Infect. 2021 Apr;27(4):639-640. doi: 10.1016/j.cmi.2020.09.039. Epub 2020 Sep 29.
4
Impact of convalescent and nonimmune plasma on mortality of patients with COVID-19: a potential role for antithrombin.
Clin Microbiol Infect. 2021 Apr;27(4):637-638. doi: 10.1016/j.cmi.2020.09.007. Epub 2020 Sep 9.
本文引用的文献
1
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. doi: 10.1016/j.jacc.2020.05.001. Epub 2020 May 6.
2
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.
3
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
4
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
5
Clinical Characteristics of Covid-19 in New York City.
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
6
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
7
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
8
Extended duration of thromboprophylaxis for medically ill patients: a systematic review and meta-analysis of randomised controlled trials.
Intern Med J. 2020 Feb;50(2):192-199. doi: 10.1111/imj.14417.
9
Venous thromboembolism prophylaxis with anticoagulation in septic patients: a prospective cohort study.
QJM. 2015 Mar;108(3):197-204. doi: 10.1093/qjmed/hcu183. Epub 2014 Sep 3.
10
Avoiding blunders involving 'immortal time'.
Int J Epidemiol. 2014 Jun;43(3):949-61. doi: 10.1093/ije/dyu105. Epub 2014 Apr 23.
Zotero 插件